M.I. Castillejo

596 total citations
12 papers, 197 citations indexed

About

M.I. Castillejo is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Oncology. According to data from OpenAlex, M.I. Castillejo has authored 12 papers receiving a total of 197 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 6 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in M.I. Castillejo's work include Genetic factors in colorectal cancer (10 papers), Cancer Genomics and Diagnostics (4 papers) and Colorectal Cancer Treatments and Studies (4 papers). M.I. Castillejo is often cited by papers focused on Genetic factors in colorectal cancer (10 papers), Cancer Genomics and Diagnostics (4 papers) and Colorectal Cancer Treatments and Studies (4 papers). M.I. Castillejo collaborates with scholars based in Spain, United States and Peru. M.I. Castillejo's co-authors include José Luís Soto, Adela Castillejo, Víctor Manuel Barberá, Carla Guarinós, Cecilia Egoavil, Lucía Pérez–Carbonell, Cristina Alenda, Artemio Payá, Gloria Peiró and Juan Carlos Martínez Escoriza and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and BMC Cancer.

In The Last Decade

M.I. Castillejo

12 papers receiving 196 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.I. Castillejo Spain 8 138 99 79 63 25 12 197
Sheila Goff United Kingdom 5 149 1.1× 110 1.1× 44 0.6× 38 0.6× 24 1.0× 5 219
Jolanta Szymańska-Pasternak Poland 9 37 0.3× 43 0.4× 45 0.6× 93 1.5× 33 1.3× 15 220
Ludovica Grassi Italy 5 32 0.2× 40 0.4× 54 0.7× 70 1.1× 22 0.9× 12 167
Daliah Tsoref Israel 6 25 0.2× 59 0.6× 33 0.4× 66 1.0× 11 0.4× 15 166
Laura Sarantaus Finland 10 139 1.0× 97 1.0× 134 1.7× 177 2.8× 26 1.0× 16 430
Guy Rosner Israel 8 76 0.6× 45 0.5× 31 0.4× 40 0.6× 22 0.9× 19 212
Chenglu Qin China 10 15 0.1× 108 1.1× 22 0.3× 54 0.9× 38 1.5× 17 281
Daron Street United States 8 37 0.3× 88 0.9× 35 0.4× 68 1.1× 36 1.4× 11 271
Baoxia Gu China 4 22 0.2× 40 0.4× 60 0.8× 64 1.0× 10 0.4× 6 238
Einav Simon Israel 9 17 0.1× 44 0.4× 28 0.4× 59 0.9× 13 0.5× 16 141

Countries citing papers authored by M.I. Castillejo

Since Specialization
Citations

This map shows the geographic impact of M.I. Castillejo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.I. Castillejo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.I. Castillejo more than expected).

Fields of papers citing papers by M.I. Castillejo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.I. Castillejo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.I. Castillejo. The network helps show where M.I. Castillejo may publish in the future.

Co-authorship network of co-authors of M.I. Castillejo

This figure shows the co-authorship network connecting the top 25 collaborators of M.I. Castillejo. A scholar is included among the top collaborators of M.I. Castillejo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.I. Castillejo. M.I. Castillejo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Castillejo, Adela, Mercedes Robledo, Àlex Teulé, et al.. (2024). Genetic and clinical characterization of a novel FH founder mutation in families with hereditary leiomyomatosis and renal cell cancer syndrome. Orphanet Journal of Rare Diseases. 19(1). 26–26. 1 indexed citations
2.
Castillejo, M.I., et al.. (2021). Co‐occurrence of germline pathogenic variants for different hereditary cancer syndromes in patients with Lynch syndrome. Cancer Communications. 41(3). 218–228. 8 indexed citations
3.
Galiana, Antonio, Victoria Sánchez, Eva Hernández‐Illán, et al.. (2017). Streptococcus gallolyticus infection in colorectal cancer and association with biological and clinical factors. PLoS ONE. 12(3). e0174305–e0174305. 32 indexed citations
4.
Díez‐Obrero, Virginia, Eva Hernández‐Illán, M.I. Castillejo, et al.. (2017). Characterization of a novel POLD1 missense founder mutation in a Spanish population. The Journal of Gene Medicine. 19(4). 4 indexed citations
5.
Egoavil, Cecilia, Cristina Alenda, Adela Castillejo, et al.. (2013). Prevalence of Lynch Syndrome among Patients with Newly Diagnosed Endometrial Cancers. PLoS ONE. 8(11). e79737–e79737. 83 indexed citations
6.
Castillejo, Adela, M.I. Castillejo, Eva Hernández‐Illán, et al.. (2012). TGFBR1 Intralocus Epistatic Interaction as a Risk Factor for Colorectal Cancer. PLoS ONE. 7(1). e30812–e30812. 4 indexed citations
7.
Castillejo, Adela, Rodrigo Jover, M.I. Castillejo, et al.. (2012). Recurrent Testicular Germ Cell Tumors in a Family With MYH-Associated Polyposis. Journal of Clinical Oncology. 30(23). e216–e217. 2 indexed citations
8.
Egoavil, Cecilia, Paola Montenegro, José Luís Soto, et al.. (2011). Clinically important molecular features of Peruvian colorectal tumours: high prevalence of DNA mismatch repair deficiency and low incidence of KRAS mutations. Pathology. 43(3). 228–233. 12 indexed citations
9.
Guarinós, Carla, Adela Castillejo, Víctor Manuel Barberá, et al.. (2010). EPCAM Germ Line Deletions as Causes of Lynch Syndrome in Spanish Patients. Journal of Molecular Diagnostics. 12(6). 765–770. 18 indexed citations
10.
Guillén‐Ponce, Carmen, Adela Castillejo, Víctor Manuel Barberá, et al.. (2009). Biallelic MYH germline mutations as cause of Muir-Torre syndrome. Familial Cancer. 9(2). 151–154. 7 indexed citations
11.
Castillejo, Adela, Paola Montenegro, M.I. Castillejo, et al.. (2009). The TGFBR1*6A allele is not associated with susceptibility to colorectal cancer in a Spanish population: a case-control study. BMC Cancer. 9(1). 193–193. 13 indexed citations
12.
Castillejo, Adela, Carla Guarinós, M.I. Castillejo, et al.. (2009). The Int7G24A variant of transforming growth factor-beta receptor type I is a risk factor for colorectal cancer in the male Spanish population: a case-control study. BMC Cancer. 9(1). 406–406. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026